Skip to main content
. 2012 Aug 15;12:355. doi: 10.1186/1471-2407-12-355

Table 1.

Paclitaxel-induced peripheral neuropathy in the study groups

 
Peripheral neuropathy
  Normal Mild Moderate Severe Total
Omega- 3 supplemented group
21(70%)
4(13.3%)
5(16.7%)
0%
30(100%)
Placebo received group 11(40.7%) 10(37%) 5(18.5%) 1(3.7%) 27(100%)

A significant difference in PN incidence (OR = 0.3, .95% CI = (0.10 - 0.88), p = 0.029).

No significant difference in severity of PN (B = −1.02, .95% CI = (−2.06 - 0.02), p = 0.054).